LivaNova PLC

자세한 내용은 LivaNova PLC 회사

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.

회사 정보

종목 코드 LIVN

회사 이름LivaNova PLC

상장일Oct 19, 2015

CEOMr. Vladimir A. Makatsaria

직원 수2900

유형Ordinary Share

회계 연도 종료Oct 19

주소20 Eastbourne Terrace

도시LONDON

증권 거래소NASDAQ Global Select Consolidated

국가United Kingdom

우편 번호W2 6LG

전화442033250662

웹사이트https://www.livanova.com/

종목 코드 LIVN

상장일Oct 19, 2015

CEOMr. Vladimir A. Makatsaria

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

--

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

--

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Francesco Bianchi

Independent Director

10.53K

+39.96%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Franco Poletti ,

President, Cardiopulmonary Business Unit

8.15K

+2.76%

Ms. Brooke Story

Independent Director

6.48K

+86.48%

Mr. Michael Damon Hutchinson

Senior Vice President, Chief Legal Officer, Company Secretary

5.67K

--

Ahmet Tezel

Senior Vice President, Chief Innovation Officer

1.94K

--

이름

이름/직위

직위

주식 보유

변동

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

--

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

--

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Francesco Bianchi

Independent Director

10.53K

+39.96%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

데이터 없음

지역별USD

이름

수익

비율

United States

169.16M

53.39%

Rest of World

87.99M

27.77%

Europe

59.70M

18.84%

사업별

지역별

데이터 없음

주식 보유 통계

마지막 업데이트: Sat, May 17

주주

주주 유형

주주

비율

BlackRock Institutional Trust Company, N.A.

11.97%

PRIMECAP Management Company

8.45%

The Vanguard Group, Inc.

4.87%

State Street Global Advisors (US)

3.85%

Capital Research Global Investors

3.81%

Other

67.05%

주주

비율

BlackRock Institutional Trust Company, N.A.

11.97%

PRIMECAP Management Company

8.45%

The Vanguard Group, Inc.

4.87%

State Street Global Advisors (US)

3.85%

Capital Research Global Investors

3.81%

Other

67.05%

주주 유형

주주

비율

Investment Advisor

50.40%

Investment Advisor/Hedge Fund

30.34%

Hedge Fund

15.63%

Research Firm

3.10%

Pension Fund

1.48%

Bank and Trust

1.30%

Venture Capital

0.73%

Individual Investor

0.38%

Sovereign Wealth Fund

0.22%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

563

56.51M

103.64%

-7.03M

2025Q1

581

56.61M

103.82%

-8.04M

2024Q4

586

56.98M

104.84%

-8.56M

2024Q3

563

55.15M

101.56%

-9.48M

2024Q2

546

57.21M

105.64%

-8.52M

2024Q1

547

58.00M

107.51%

-6.90M

2023Q4

532

56.62M

105.11%

-7.28M

2023Q3

527

56.14M

104.20%

-8.51M

2023Q2

529

55.56M

103.33%

-9.55M

2023Q1

544

57.05M

106.52%

-4.67M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

BlackRock Institutional Trust Company, N.A.

6.53M

11.97%

-36.05K

-0.55%

Mar 31, 2025

PRIMECAP Management Company

4.61M

8.45%

-145.65K

-3.06%

Mar 31, 2025

The Vanguard Group, Inc.

2.65M

4.87%

+316.99K

+13.56%

Mar 31, 2025

State Street Global Advisors (US)

2.10M

3.85%

-950.00

-0.05%

Mar 31, 2025

Capital Research Global Investors

2.08M

3.81%

+465.61K

+28.87%

Mar 31, 2025

Millennium Management LLC

2.07M

3.79%

-983.66K

-32.27%

Mar 31, 2025

AQR Capital Management, LLC

1.57M

2.88%

+829.12K

+111.71%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.41M

2.59%

+73.94K

+5.53%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

1.33M

2.44%

+20.96K

+1.60%

Mar 31, 2025

Emerald Advisers LLC

1.22M

2.24%

-5.17K

-0.42%

Mar 31, 2025

42.530USD

LivaNova PLC

42.530

개요

회사

금융